David van de Vijver - JoVE Visualize

Showing results (1-10 of 33) with videos related to

Pageof 4

Sort By:

Journal of Acquired Immune Deficiency Syndromes (1999)|May 25, 2026

Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling studyHaoyi Wang, Kai J Jonas, David van de Vijver

AIDS Care|May 7, 2024

Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approachHaoyi Wang, Hanne M L Zimmermann, David van de Vijver, et al.

BMC Infectious Diseases|May 17, 2011

Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in AmsterdamShan Mei, Rick Quax, David van de Vijver, et al.

Intensive Care Medicine|November 19, 2009

Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteriaSaskia Nijssen, Ad Fluit, David van de Vijver, et al.

Infectious Diseases (London, England)|February 8, 2019

Is HIV-1 viraemia below 20 copies/mL in antiretroviral-treated patients associated with virologic outcome?Myriam den Oudsten, Jeroen van Kampen, Bart Rijnders, et al.

Journal of Virus Eradication|November 23, 2019

Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-savingStephanie Popping, Brooke Nichols, Bart Rijnders, et al.

Journal of the International AIDS Society|November 14, 2014

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV CohortCasper Rokx, Azzania Fibriani, David van de Vijver, et al.

Viruses|September 28, 2024

Mapping Transmission Dynamics and Drug Resistance Surveillance in the Cyprus HIV-1 Epidemic (2017-2021)Cicek Topcu, Bram Vrancken, Johana Hezka Rodosthenous, et al.

PLOS Global Public Health|March 24, 2023

Clinical outcomes among adolescents living with HIV in Kenya following initiation on antiretroviral treatmentJudith Kose, Appolinaire Tiam, Stephen Siamba, et al.

Journal of Virus Eradication|June 18, 2021

Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: A cost effectiveness modelling studyShreoshee Mukherjee, Donn Colby, Reshmie Ramautarsing, et al.

Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:

Pageof 4

Journal of Acquired Immune Deficiency Syndromes (1999)|May 25, 2026

Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling studyHaoyi Wang, Kai J Jonas, David van de Vijver

AIDS Care|May 7, 2024

Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approachHaoyi Wang, Hanne M L Zimmermann, David van de Vijver, et al.

BMC Infectious Diseases|May 17, 2011

Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in AmsterdamShan Mei, Rick Quax, David van de Vijver, et al.

Intensive Care Medicine|November 19, 2009

Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteriaSaskia Nijssen, Ad Fluit, David van de Vijver, et al.

Infectious Diseases (London, England)|February 8, 2019

Is HIV-1 viraemia below 20 copies/mL in antiretroviral-treated patients associated with virologic outcome?Myriam den Oudsten, Jeroen van Kampen, Bart Rijnders, et al.

Journal of Virus Eradication|November 23, 2019

Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-savingStephanie Popping, Brooke Nichols, Bart Rijnders, et al.

Journal of the International AIDS Society|November 14, 2014

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV CohortCasper Rokx, Azzania Fibriani, David van de Vijver, et al.

Viruses|September 28, 2024

Mapping Transmission Dynamics and Drug Resistance Surveillance in the Cyprus HIV-1 Epidemic (2017-2021)Cicek Topcu, Bram Vrancken, Johana Hezka Rodosthenous, et al.

PLOS Global Public Health|March 24, 2023

Clinical outcomes among adolescents living with HIV in Kenya following initiation on antiretroviral treatmentJudith Kose, Appolinaire Tiam, Stephen Siamba, et al.

Journal of Virus Eradication|June 18, 2021

Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: A cost effectiveness modelling studyShreoshee Mukherjee, Donn Colby, Reshmie Ramautarsing, et al.

Pageof 4